{
	"symbol": "HBP",
	"name": "Helix BioPharma Corp.",
	"price": 0.77,
	"priceChange": 0.07,
	"percentChange": 10,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 7560,
	"openPrice": 0.75,
	"dayHigh": 0.77,
	"dayLow": 0.75,
	"MarketCap": 37746594,
	"MarketCapAllClasses": 37746583,
	"peRatio": "",
	"prevClose": 0.7,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": -0.844863,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.",
	"fulldescription": "Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.",
	"website": "https://www.helixbiopharma.com",
	"email": "helix@helixbiopharma.com",
	"phoneNumber": "+1 905 841-2300",
	"fullAddress": "9120 Leslie Street,Suite 205, Suite 2704, Richmond Hill, ON, CA",
	"employees": "7",
	"shareOutStanding": 49021550,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 49021536,
	"sharesESCROW": null,
	"vwap": 0.752666666,
	"dividendPayDate": null,
	"weeks52high": 1.35,
	"weeks52low": 0.5,
	"alpha": -0.007075,
	"averageVolume10D": 28315,
	"averageVolume20D": 20110,
	"averageVolume30D": 16909,
	"averageVolume50D": 10698,
	"priceToBook": -419.41,
	"priceToCashFlow": -12.6,
	"returnOnEquity": "",
	"returnOnAssets": -316.68,
	"day21MovingAvg": 0.76381,
	"day50MovingAvg": 1.007,
	"day200MovingAvg": 1.051425,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 0.77,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}